|
|
Avandia - News Articles
-
-
The National Venture Capital Association and medical device trade groups argue that the FDA, stung by high-profile safety controversies in recent years (stents, Vioxx, Avandia), has become so fixated on risks that it is stifling innovation in an industry where the United States has a competitive edge. FDA reviews of medical device applications, critics say, have become ...
-
-
Also, the numbers were hit by the loss of revenue from its Avandia diabetes medicine, which the company has stopped promoting because of an increased risk of heart attacks, and generic competition to its Valtrex treatment for genital herpes. Related Articles Glaxo ventures into fragile markets with Somalian sale 30 Apr 2011 Glaxo profit helped by disposals as ...
-
-
In the 7 phase 3 trials examined in the metaanalysis, liraglutide was compared with placebo, exenatide, insulin glargine, glimepiride, rosiglitazone, and sitagliptin. The metaanalysis included the 6 clinical trials that led to the approval by the US ...
-
-
Rosiglitazone (Avandia) will become an Authority Required PBS item to reflect concern regarding its side effects, the Pharmaceutical Benefits Advisory Committee (link) says. It has also approved new or extended PBS listings for several other drugs including dabigatran, risperidone, risedronate and fentanyl patches. The new approvals join a list of ...
-
-
Medicare figures show there were 7966 prescriptions for rosiglitazone (Avandia and Avandamet) in March this year. This represents . Please login to read full article. To view full articles and make the most of Endocrinology Update, you need to be logged in and a registered Healthcare Practitioner. Login now elem = document.getElementById("categoryblock"); elem.style.display = "none"; to get Endocrinology Update ...
-
-
The Pharma Letter (subscription)
The EU decided to pull Avandia owing to concerns over its active substance rosiglitazone. It decided also to halt the sale of Glaxo's other diabetes drugs, Avandamet and Avaglim, since they too contained rosiglitazone. ...
-
-
We knew in August of last year that the FDA had asked for a criminal investigation of the company over whether it made false statements to the agency regarding its diabetes drug, Avandia. The feds have a particular, easily documented financial beef over Avandia: 8 percent of all Avandia sales were to the Veterans Administration , and veterans were the subject ...
-
-
Although there are other PPAR drugs currently on the market for the treatment of type 2 diabetes, such as rosiglitazone and pioglitazone, DB959 is in a different chemical class and has demonstrated a very different preclinical safety and pharmacological profile. Appears safe and effective Continued on Next page >> Related posts Diabetes and prediabetes are on the ...
-
-
April 27, 2011
PharmaTimes
Also generic competition cut sales of Valtrex (valaciclovir) for herpes by 51% to £90 million, while the controversial Avandia (rosiglitazone) diabetes franchise slumped 79% to £36 million; sales of Avandia have been suspended in Europe and its use has ...
-
-
MARSHALL - A year after a Gilmer resident died while taking the diabetic drug Avandia, his family has filed a wrongful death lawsuit against the drug's manufacturer. Jason Mark Knight, Janice East and Janet Knight, individually and as independent administrator of the estate of James Michael Knight, deceased, filed suit against Smithkline Beecham Corp., Glaxosmithkline and Smithkline Beecham ...
-
-
Bloomberg
GSK was rocked in September when the EU medicines regulator decided to pull its former diabetes product Avandia off the shelves over fears that it increased the risk of heart attack and strokes. Regulators also restricted its availability in the United ...
-
-
The charge – announced in January – partly related to litigation around Glaxo's diabetes drug, Avandia. When Glaxo updates the market this week, investors might well be interested to hear more about Glaxo's reasons for selling off Alli, its weight loss drug, as part of an overhaul of its non-prescription medicine business. Earlier this month, the drug maker said that ...
-
-
The argument from the National Venture Capital Association and medical device trade groups is that the FDA, stung by high-profile safety controversies in recent years (think cardiac stents, Vioxx, Avandia), has become so fixated on risks of new products that it is stifling innovation in an industry where the U.S. has a competitive edge. FDA reviews of ...
-
-
Although there are other PPAR drugs currently on the market for the treatment of type 2 diabetes, such as rosiglitazone and pioglitazone, DB959 is in a different chemical class and has demonstrated a very different preclinical safety and pharmacological profile. Appears safe and effective In preclinical studies, DB959 appears to have a favorable effect on blood lipids ...
-
-
There have been well-publicised problems with its Avandia diabetes product. Glaxo has responded by streamlining its businesses and also investing in growth areas with the aim of boosting cash generation. Its efforts are likely to bear fruit in 2012, when it expects to return to profits growth. The pipeline of possible new drugs also looks a little better, ...
-
-
The medication rosiglitazone has been proven effective in reducing the blood sugar of patients with type 2 diabetes. However, it has also been linked to an increased risk of cardiovascular problems. A new study has confirmed these risks, and its authors warn that there may be safer alternatives. A team of researchers from the University of East ...
-
-
Spirulina protects against rosiglitazone induced osteoporosis in insulin resistance rats. Diabetes Res Clin Pract. 2010 Jan;87(1):38-43. McCarty MF, Barroso-Aranda J, Contreras F. NADPH oxidase mediates glucolipotoxicity-induced beta cell dysfunction--clinical implications. Med Hypotheses. 2010 Mar;74(3):596-600. Palmquist RE. 2008. Apparent response to homotoxicology, salmon oil and blue-green algae in ...
-
-
American Council on Science and Health
Pioglitazone, sold under the brand name Actos, belongs to the same class of drugs as the diabetes medication rosiglitazone, sold as Avandia, which was found to increase the risk of heart attack in patients taking it. Rosiglitazone was taken off the market in Europe, and its use is greatly restricted in the United States. Pioglitazone is believed to be safer ...
-
-
The list of drug patents expected to expire in 2012 is longer: Actos (diabetes), Avandia (diabetes), Avapro and Avalide (high blood pressure), Clarinex (allergy symptoms), Diovan/Diovan HCT (high blood pressure), Geodon (schizophrenia, bipolar disorder), Lescol XL (high cholesterol), Lexapro (depression, anxiety), Plavix (blood clot prevention), Provigil (excessive sleepiness), Seroquel (schizophrenia, bipolar ...
-
-
The BBC said that Avandia, also known as rosiglitazone, was suspended in Europe but is still available in the US and Canada. Avandia is the brand name of the diabetic drug rosiglitazone, which was banned in 2010 after the European Medicines Agency concluded that its benefits did not outweigh the cardiovascular risks. Actos is the brand name of pioglitazone, a drug ...
Pages:
1
2
3
4
5
6
...
Next
|
|
